<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="10023">Voriconazole</z:chebi> is a new <z:chebi fb="0" ids="38597">triazole</z:chebi> active orally and parenterally that recently proved effective in the treatment of invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> and in empirical antifungal therapy for persistently febrile neutropenic patients </plain></SENT>
<SENT sid="1" pm="."><plain>Limited data are available for pediatric patients </plain></SENT>
<SENT sid="2" pm="."><plain>We report our experience with <z:chebi fb="0" ids="10023">voriconazole</z:chebi> in seven children with invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e>, i.e., four girls and three boys with a median age of 5 (range 2-13) years affected by <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (3), <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (2), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (1), and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (1) </plain></SENT>
<SENT sid="3" pm="."><plain>First-line therapy in <z:hpo ids='HP_0000001'>all</z:hpo> patients was <z:chebi fb="0" ids="2682">liposomal amphotericin B</z:chebi> (AmBisome) administered at a dosage of 3-5 mg/kg day </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="10023">Voriconazole</z:chebi> was administered for a median 8 (range 2-15) weeks </plain></SENT>
<SENT sid="5" pm="."><plain>Response was complete and partial in two patients, respectively, stable in one, and there was no response (failure) in two </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="0" ids="10023">voriconazole</z:chebi> treatment was well tolerated </plain></SENT>
<SENT sid="7" pm="."><plain>Four patients died-two of progressive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Three patients are alive and well 6, 5, and 4 months after the diagnosis of <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="10023">Voriconazole</z:chebi> appears to be an effective salvage treatment for invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> in pediatric patients, with good responses in patients who recover from <z:hpo ids='HP_0001875'>neutropenia</z:hpo> or are not relapsing </plain></SENT>
</text></document>